Hawaii attorney general sues maker of drug Plavix (Update)

March 19, 2014 by Jennifer Sinco Kelleher

Hawaii's attorney general is suing the makers of a widely prescribed blood thinner that he says a significant portion of the state's population has difficulty metabolizing.

Attorney General David Louie filed a lawsuit Wednesday against the manufacturers and distributors of Plavix, marketed to work similarly to aspirin to prevent a stroke or heart attack.

Louie says the drugmaker didn't disclose that Plavix would have diminished or no effect on people of East Asian and Pacific Islander ancestry. He says the drug puts them at risk for gastrointestinal bleeding and other complications.

The suit names Bristol-Myers Squibb and Sanofi-Aventis as defendants. In a joint statement, the companies said they won't comment on pending litigation.

Sanofi last year said the U.S. Justice Department was investigating its disclosures to the Food and Drug Administration about different responses to Plavix. It provided no details but said it was cooperating with the probe.

Related Stories

Genetic test for Plavix use may be unneeded: study

December 29, 2011

A new study published Wednesday cast doubt on the usefulness of a genetic test for patients taking the anti-coagulant drug Plavix, calling into question last year's FDA warning about the blood thinner.

Bristol-Myers, Sanofi revamp Plavix sales alliance (Update)

October 3, 2012

(AP)—Bristol-Myers Squibb Co. and France's Sanofi SA said Wednesday that they are restructuring their longtime partnership selling popular heart medications, now that their sales are plunging due to widespread competition ...

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.